Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Did you get the rest of your fill Davgro ?

<< Previous

Bullboard Posts

Next >>

Comment by davgroon Nov 08, 2022 4:23pm

157 Views

Post# 35083352

RE:Did you get the rest of your fill Davgro ?

MrMugsy wrote: She hit 48 at the end - did you get more ?

I got another 1000 shares just before the close for a total of 9,500 of my original 20,000 share order.

Its frustratating that TD charges me $7 commission for a $480 fill but ever since they removed the All or None order back in 2009 there is no control over the size of your fills. Its okay, I expect a big winfall on ATE down the road so its a small incremental cost to pay to accumulate cheap shares.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec